MicroRNAs as the critical regulators of Doxorubicin resistance in breast tumor cells
Abstract Background Chemotherapy is one of the most common treatment options for breast cancer (BC) patients. However, about half of the BC patients are chemotherapeutic resistant. Doxorubicin (DOX) is considered as one of the first line drugs in the treatment of BC patients whose function is negati...
Main Authors: | Amir Sadra Zangouei, Maliheh Alimardani, Meysam Moghbeli |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-04-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-021-01873-4 |
Similar Items
-
MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells
by: Amir Sadra Zangouei, et al.
Published: (2021-06-01) -
MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells
by: Meysam Moghbeli
Published: (2021-09-01) -
MicroRNAs as the critical regulators of protein kinases in prostate and bladder cancers
by: Malihe Zangoue, et al.
Published: (2021-09-01) -
Long non-coding RNAs as the critical regulators of doxorubicin resistance in tumor cells
by: Ghazaleh Khalili-Tanha, et al.
Published: (2021-08-01) -
microRNAs associated to anthracycline-induced cardiotoxicity in women with breast cancer: A systematic review and pathway analysis
by: Jéssica Diniz Pereira, et al.
Published: (2020-11-01)